1999
Effects of Vigabatrin on the GABAergic System as Determined by [123I]Iomazenil SPECT and GABA MRS
Verhoeff N, Petroff O, Hyder F, Zoghbi S, Fujita M, Rajeevan N, Rothman D, Seibyl J, Mattson R, Innis R. Effects of Vigabatrin on the GABAergic System as Determined by [123I]Iomazenil SPECT and GABA MRS. Epilepsia 1999, 40: 1433-1438. PMID: 10528940, DOI: 10.1111/j.1528-1157.1999.tb02016.x.Peer-Reviewed Original ResearchConceptsEffects of vigabatrinGABA levelsTissue GABA levelsMR imagingCentral gamma-aminobutyric acidGABA magnetic resonance spectroscopyDistribution volumeHealthy age-matched controlsOccipital GABA levelsAge-matched controlsGamma-aminobutyric acidVolume of interestSingle photon emissionMagnetic resonance spectroscopyTotal plasma activityT1-weighted MR imagingPartial seizuresGABAergic systemOccipital cortexConstant infusion methodPlasma activityVigabatrinOccipital activityEffective doseWilcoxon testAcute Effects of Vigabatrin on Brain GABA and Homocarnosine in Patients with Complex Partial Seizures
Petroff O, Hyder F, Collins T, Mattson R, Rothman D. Acute Effects of Vigabatrin on Brain GABA and Homocarnosine in Patients with Complex Partial Seizures. Epilepsia 1999, 40: 958-964. PMID: 10403220, DOI: 10.1111/j.1528-1157.1999.tb00803.x.Peer-Reviewed Original ResearchConceptsBrain gamma-aminobutyric acidGamma-aminobutyric acidDose of vigabatrinComplex partial seizuresPartial seizuresRefractory complex partial seizuresFirst oral doseVGB therapyFirst doseFurther seizuresAdjunct therapyDay dosingOral doseAcute effectsOral administrationOccipital cortexMedian increasePatientsVigabatrinChronic effectsNormal levelsPartial protectionSeizuresDoseHomocarnosineLocalized 1H NMR measurements of 2‐pyrrolidinone in human brain in vivo
Hyder F, Petroff O, Mattson R, Rothman D. Localized 1H NMR measurements of 2‐pyrrolidinone in human brain in vivo. Magnetic Resonance In Medicine 1999, 41: 889-896. PMID: 10332870, DOI: 10.1002/(sici)1522-2594(199905)41:5<889::aid-mrm6>3.0.co;2-r.Peer-Reviewed Original ResearchGABA Changes with Vigabatrin in the Developing Human Brain
Novotny E, Hyder F, Shevell M, Rothman D. GABA Changes with Vigabatrin in the Developing Human Brain. Epilepsia 1999, 40: 462-466. PMID: 10219272, DOI: 10.1111/j.1528-1157.1999.tb00741.x.Peer-Reviewed Original ResearchConceptsBrain GABA levelsGABA levelsBrain GABAVGB treatmentRole of GABASeizure controlGABA changesSeizure susceptibilityPediatric epilepsyEpileptic focusOccipital lobeNervous systemEpileptic regionsVigabatrinEpilepsyGABAGABA metabolismTreatmentAge 1Noninvasive measurementHuman brainSubjectsDrugsFivefold increaseChildren
1998
Vigabatrin increases human brain homocarnosine and improves seizure control
Petroff O, Mattson R, Behar K, Hyder F, Rothman D. Vigabatrin increases human brain homocarnosine and improves seizure control. Annals Of Neurology 1998, 44: 948-952. PMID: 9851440, DOI: 10.1002/ana.410440614.Peer-Reviewed Original ResearchConceptsGamma-aminobutyric acidSeizure controlGABA concentrationAddition of vigabatrinLow-dose vigabatrinImproved seizure controlMean GABA concentrationAntiepileptic drug vigabatrinInhibitory neuromodulatorDaily doseGABAergic neuronsGABA levelsLarge dosesHomocarnosine concentrationsVigabatrinDrug vigabatrinHomocarnosinePatientsHuman brainMagnetic resonance spectroscopyControlNeuromodulatorsNeuronsDoseDoses